Nanobiotix SA NBTX Q4 2025 Earnings Wide EPS Miss Stock Edges Higher on Clinical Progress FSUN Q1 2026 Earnings EPS Falls Short of Analyst Expectations Shares Edge Lower AGM Q1 2026 Earnings EPS Surpasses Estimates Stock Edges Higher TE Connectivity Q1 2026 Earnings Modest EPS Beat Amid Steady Operational Execution XOMAP Q1 2026 Earnings Preferred Stock Reports EPS Miss Amid Royalty Revenue Uncertainty CALC Q1 2026 Earnings Surprising Profit on a PerShare Basis Yet Shares Decline